Pharmaceutical

Merida launches with $121m to target autoimmune antibodies

The funding will be used to advance Merida’s lead programme in the autoimmune condition, Graves’ disease.

Apr 10, 2025 - 06:00
Merida launches with $121m to target autoimmune antibodies
The funding will be used to advance Merida’s lead programme in the autoimmune condition, Graves’ disease.
Read the original article

Tags:

Previous Article

FDA approves injectable antibiotics for B Braun drug delivery system

Next Article

IRA holds the scope to shape pharma’s research strategy, say experts

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Bavarian Nordic outlays 215,000 mpox vaccine dose supply to African countries

Bavarian Nordic outlays 215,000 mpox vaccine dose suppl...

Aug 15, 2024

FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV

FDA advisers recommend approval of monoclonal antibody ...

Jun 8, 2023

Rani reports positive data for non-injectable Stelara biosimilar

Rani reports positive data for non-injectable Stelara b...

Feb 6, 2024